Hematology Month in Review: March 2024
Our March 2024 month-in-review in hematology features updates to the anemia pipeline, the latest research in sickle cell disease, and the role of SGLT2 inhibition on hematologic outcomes.
Source: hcplive.com
Kieranf Docherty News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Kieranf Docherty. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Kieranf Docherty Today - Breaking & Trending Today
False Positives: Common Drug Discovered To Interfere With Alzheimer's Blood Tests
Alzheimer's disease (AD) is linked to harmful protein accumulations in the brain, primarily β-amyloid (Aβ) aggregates known as plaques, which are central to the disease's pathology. Entresto (sacubitril/valsartan) is a combined neprilysin inhibitor and angiotensin receptor blocker, approved for the
Source: scitechdaily.com
Dapagliflozin Early Benefit Explored in Reduced-EF Heart Failure
Why have SGLT2-inhibitor clinical benefits in HFrEF trials been evident so soon after the drugs are started? Recent studies shed light on one potential mechanism among what are probably many.
Source: medscape.com